Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Rachel M. F. Heilmann"'
Publikováno v:
Family Practice. 38:623-629
Background While use of glucagon-like peptide-1 (GLP-1) agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitors reduces the risk of atherosclerotic cardiovascular disease outcomes and lowers glycosylated haemoglobin (A1C), evidence on patient
Autor:
Rachel M. F. Heilmann, Rolake Kuye, Catherine S. Riggs, Jordan B. King, Jessica L. Milchak, Deanna Kurz
Publikováno v:
Ann Fam Med
The purpose of this retrospective matched-cohort study was to evaluate the stability of thyroid stimulating hormone (TSH) in patients using synthetic compared with desiccated thyroid products. Patients using a thyroid product for the treatment of hyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccd85d27d35d0216db200f187c916ed9
https://europepmc.org/articles/PMC7489980/
https://europepmc.org/articles/PMC7489980/
Opioid Use for Pain Management After Implementation of a Medicaid Short-Acting Opioid Quantity Limit
Autor:
Samantha Flores, Catherine S. Riggs, Sarah J. Billups, Rachel M. F. Heilmann, Jessica L. Milchak, Rachana J. Patel
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 23:346-354
The United States is currently experiencing an opioid abuse epidemic. Many policies and programs have been implemented at local, state, and national levels in an attempt to decrease prescription opioid addiction and overdose. On August 1, 2014, Color
Autor:
Jenel R Proksel, Rachel M. F. Heilmann, Stephanie M Campbell, Dennis K. Helling, Sarah J. Billups, Daniel M. Witt, Beverly A. Kroner
Publikováno v:
Annals of Pharmacotherapy. 47:124-131
The impact of the declining number of primary care physicians is exacerbated by a growing elderly population in need of chronic disease management. Primary care clinical pharmacy specialists, with their unique knowledge and skill set, are well suited
Publikováno v:
American Journal of Health-System Pharmacy. 69:504-509
Purpose The impact of decentralized clinical pharmacy services on the implementation of appropriate care in postmenopausal women with a recent history of a fracture was assessed. Methods Women 67 years of age or older with a documented fracture betwe
Publikováno v:
Pharmacotherapy. 35(3)
Study Objective To compare costs associated with two osteoporosis management interventions and to quantify cost avoidance due to projected hip fracture prevention. Design Labor and cost analysis within a retrospective cohort study. Setting Integrated
Autor:
Jessica L. Milchak, Rachel M. F. Heilmann, A. D. Cizmic, Catherine S. Riggs, Sarah J. Billups
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 26(8)
Osteoporosis (weak bones) is a disorder that has high morbidity, mortality, and healthcare utilization. Effective treatment is available for this disorder, but many patients choose not to start therapy. This is the first study showing an intervention
Autor:
Theresa M. Gerrity, Rachel M. F. Heilmann, Kari L. Olson, Beverly A. Kroner, Adriane N. Irwin
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 71(23)
Purpose The ability of a pharmacy technician to support the patient screening and documentation-related functions of a pharmacist-driven osteoporosis management service was evaluated. Methods A two-phase prospective study was conducted within a large
Publikováno v:
Journal of the American Geriatrics Society. 61(11)
Autor:
IRWIN, ADRIANE N.1, HEILMANN, RACHEL M. F.2,3 rachel.m.heilmann@kp.org, GERRITY, THERESA M4, KRONER, BEVERLY A.5, OLSON, KARI L.6,7
Publikováno v:
American Journal of Health-System Pharmacy. 12/1/2014, Vol. 71 Issue 23, p2054-2059. 6p. 3 Charts.